Trials / Not Yet Recruiting
Not Yet RecruitingNCT07278583
Evaluation of Heart Failure Telemonitoring Eligibility Criteria
Eligibility Criteria Evaluation of Heart Failure Telemonitoring : Analysis of CARDIAUVERGNE's Cohort
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (estimated)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to analyze the prognosis and evolution of patients after exclusion of CARDIAUVERGNE, a heart failure telemonitoring system at Clermont-Ferrand's hospital. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the french health authority criteria.
Detailed description
After an episode of heart failure, patients have been included in a telemonitoring program in order to reduce rehospitalizations for heart failure and improve follow-up. On a daily basis, the patients weigh themselves on connected scales which enables a team of dedicated nurses to follow them closely. If need be they can call the patient, ask for a blood exam and adapt their prescription. Indeed, if remote support is insufficient, patients can be hospitalized prematurely and so decrease the duration of hospital care. The inclusion criteria correspond to either an episode of heart failure in the last 12 months or dyspnea at least NYHA2 with NT-proBNP over 1000pg/mL. The follow up is renewed every 6 months. Patients are excluded from monitoring when criteria are no longer fulfilled. As these characteristics have been chosen empirically, our aim is to see if patients no longer presenting these standards have indeed a low chance of bad evolution. Information is gathered from their medical record at inclusion, exclusion and 1 year after exclusion. A short phone call is made after 1 year of exclusion, to appreciate their evolution and gather information concerning their symptoms, treatments ...
Conditions
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2025-12-12
- Last updated
- 2025-12-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07278583. Inclusion in this directory is not an endorsement.